JP2018500390A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500390A5 JP2018500390A5 JP2017549860A JP2017549860A JP2018500390A5 JP 2018500390 A5 JP2018500390 A5 JP 2018500390A5 JP 2017549860 A JP2017549860 A JP 2017549860A JP 2017549860 A JP2017549860 A JP 2017549860A JP 2018500390 A5 JP2018500390 A5 JP 2018500390A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- wnt5a
- tumor
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462090029P | 2014-12-10 | 2014-12-10 | |
| US62/090,029 | 2014-12-10 | ||
| PCT/IB2015/002577 WO2016092378A1 (en) | 2014-12-10 | 2015-12-09 | Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brian tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018500390A JP2018500390A (ja) | 2018-01-11 |
| JP2018500390A5 true JP2018500390A5 (https=) | 2019-01-24 |
| JP6921755B2 JP6921755B2 (ja) | 2021-08-18 |
Family
ID=55353245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017549860A Active JP6921755B2 (ja) | 2014-12-10 | 2015-12-09 | 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10688167B2 (https=) |
| EP (1) | EP3229831B1 (https=) |
| JP (1) | JP6921755B2 (https=) |
| KR (1) | KR102674191B1 (https=) |
| AU (1) | AU2015359043C1 (https=) |
| CA (1) | CA2970140A1 (https=) |
| DK (1) | DK3229831T3 (https=) |
| ES (1) | ES2796973T3 (https=) |
| WO (1) | WO2016092378A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10852069B2 (en) | 2010-05-04 | 2020-12-01 | Fractal Heatsink Technologies, LLC | System and method for maintaining efficiency of a fractal heat sink |
| JP6921755B2 (ja) * | 2014-12-10 | 2021-08-18 | ハイパーステム ソシエテ アノニム | 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物 |
| WO2019081657A1 (en) * | 2017-10-25 | 2019-05-02 | Wntresearch Ab | WNT5A PEPTIDES FOR REDUCING CANCER STEM CELLS |
| KR101921836B1 (ko) | 2017-11-23 | 2018-11-26 | 서울대학교병원 | 피부성체 줄기세포의 분화 조절 방법, 및 피부성체 줄기세포의 분화 조절용 조성물 및 키트 |
| EP3784240B1 (en) * | 2018-04-24 | 2023-09-20 | Universidade do Minho | Wnt6 as glioblastoma oncogenic biomarker, and uses of inhibitors thereof for treating wnt6-overexpressing glioblastoma |
| EP3613757A1 (en) * | 2018-08-20 | 2020-02-26 | Wntresearch AB | Solution phase routes for wnt hexapeptides |
| EP3666789A1 (en) * | 2018-12-14 | 2020-06-17 | Wntresearch AB | Linear solution phase routes for wnt hexapeptides |
| SG11202111476RA (en) * | 2019-04-16 | 2021-11-29 | Wntresearch Ab | Peptides in combination with immune checkpoint inhibitors for use in treatment of cancer |
| EP4013297A4 (en) | 2019-08-16 | 2023-12-13 | Poltorak Technologies, LLC | DEVICE AND METHOD FOR MEDICAL DIAGNOSTICS |
| CN114081954B (zh) * | 2021-10-30 | 2023-02-28 | 中国人民解放军陆军军医大学第一附属医院 | 用于胶质母细胞瘤治疗的药物组合物以及预后的诊断试剂 |
| CN116173048A (zh) * | 2023-01-19 | 2023-05-30 | 温州医科大学附属第一医院 | 棉子糖及其衍生物在胶质母细胞瘤治疗中的应用 |
| WO2025088835A1 (ja) * | 2023-10-25 | 2025-05-01 | 国立大学法人大阪大学 | ヒト化抗ｃｋａｐ４抗体又はその抗原結合性断片 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1521000A (en) | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device |
| US4227522A (en) | 1978-09-05 | 1980-10-14 | Syntex Puerto Rico, Inc. | Inhalation device |
| US4192309A (en) | 1978-09-05 | 1980-03-11 | Syntex Puerto Rico, Inc. | Inhalation device with capsule opener |
| US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
| DK172541B1 (da) | 1982-10-08 | 1998-12-07 | Glaxo Group Ltd | Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet |
| DE3682457D1 (de) | 1985-07-30 | 1991-12-19 | Glaxo Group Ltd | Geraet zur verabreichung von medikamenten an patienten. |
| JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| AU1700700A (en) | 1999-11-05 | 2001-05-14 | Forskarpatent I Syd Ab | Compounds, antibodies and methods for treating, preventing or diagnosing tumour metastasis |
| EP2384763B1 (en) | 2005-05-30 | 2015-04-29 | Wntresearch AB | A peptide ligand to impair cancer cell migration |
| ES2527454T3 (es) * | 2008-08-13 | 2015-01-23 | Wntresearch Ab | El uso de derivados del péptido Wnt5-a para el tratamiento de melanoma y cáncer gástrico |
| CA2786745A1 (en) * | 2010-01-12 | 2011-07-21 | Oncomed Pharmaceuticals, Inc. | Wnt-binding agents and uses thereof |
| EP2446895A1 (en) | 2010-10-01 | 2012-05-02 | Stemgen S.P.A. | EPH receptor expression in tumor stem cells |
| DK2726880T3 (da) * | 2011-07-01 | 2019-07-15 | Wntresearch Ab | Behandling af prostatacancer og fremgangsmåde til bestemmelse af prognosen for prostatacancer |
| US20140171356A1 (en) | 2012-12-12 | 2014-06-19 | The Board Of Trustees Of The Leland Stanford Junior University | Chemically immobilized wnt protein and methods of use |
| JP6921755B2 (ja) * | 2014-12-10 | 2021-08-18 | ハイパーステム ソシエテ アノニム | 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物 |
-
2015
- 2015-12-09 JP JP2017549860A patent/JP6921755B2/ja active Active
- 2015-12-09 CA CA2970140A patent/CA2970140A1/en active Pending
- 2015-12-09 US US15/533,842 patent/US10688167B2/en active Active
- 2015-12-09 DK DK15834638.7T patent/DK3229831T3/da active
- 2015-12-09 WO PCT/IB2015/002577 patent/WO2016092378A1/en not_active Ceased
- 2015-12-09 EP EP15834638.7A patent/EP3229831B1/en active Active
- 2015-12-09 AU AU2015359043A patent/AU2015359043C1/en active Active
- 2015-12-09 ES ES15834638T patent/ES2796973T3/es active Active
- 2015-12-09 KR KR1020177018938A patent/KR102674191B1/ko active Active
-
2020
- 2020-05-13 US US15/931,081 patent/US11357840B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018500390A5 (https=) | ||
| Ramer et al. | Restoring function after spinal cord injury: towards clinical translation of experimental strategies | |
| Shi et al. | Collagen scaffolds modified with collagen-binding bFGF promotes the neural regeneration in a rat hemisected spinal cord injury model | |
| JP7096592B2 (ja) | Ｊａｋ阻害剤およびこれらの利用 | |
| Kim et al. | Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regeneration | |
| JP2020040969A5 (https=) | ||
| SA521421559B1 (ar) | أجهزة قابلة للزرع للعلاج بالخلايا وطرق ذات الصلة | |
| MX2010003774A (es) | Formulaciones oftalmicas acuosas. | |
| NZ610556A (en) | Stem cell suspension | |
| WO2012071526A3 (en) | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds | |
| KR101749138B1 (ko) | 신경질환 예방 또는 치료를 위한 aimp2-dx2를 포함하는 약학 조성물 및 이의 용도 | |
| KR20190120197A (ko) | 치료 및 신경보호 펩티드 | |
| Fadeev et al. | Combination of epidural electrical stimulation with ex vivo triple gene therapy for spinal cord injury: a proof of principle study | |
| Ji et al. | Decellularized matrix of adipose-derived mesenchymal stromal cells enhanced retinal progenitor cell proliferation via the Akt/Erk pathway and neuronal differentiation | |
| Behrstock et al. | Combining growth factors, stem cells, and gene therapy for the aging brain | |
| Nakhaeifard et al. | Conditioned medium protects dopaminergic neurons in parkinsonian rats | |
| CA2797858A1 (en) | Sox9 inhibitors | |
| JP6841871B2 (ja) | 転移を阻害し、線維症を処置し、かつ創傷の治癒を向上させる方法および組成物 | |
| He et al. | Bone marrow stromal cells promote neuroplasticity of cerebral ischemic rats via a phosphorylated CRMP2-mediated mechanism | |
| WO2018039100A2 (en) | Stem cell-produced microvesicles for treating tendon pathologies | |
| CN106222173A (zh) | circRNA MNCR核苷酸、含有该核苷酸的药物组合物及其用途 | |
| Hettiaratchi et al. | Recent advances in regenerative medicine approaches for spinal cord injuries | |
| NZ732532A (en) | Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors | |
| NZ732532B2 (en) | Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors | |
| Omar Khudhur et al. | Epothilone B loaded in acellular nerve allograft enhanced sciatic nerve regeneration in rats |